Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 69

1.

Half-genome human immunodeficiency virus type 1 constructs for rapid production of reporter viruses.

Ali A, Jamieson BD, Yang OO.

J Virol Methods. 2003 Jun 30;110(2):137-42.

PMID:
12798240
2.

HLA-A2 down-regulation on primary human macrophages infected with an M-tropic EGFP-tagged HIV-1 reporter virus.

Brown A, Gartner S, Kawano T, Benoit N, Cheng-Mayer C.

J Leukoc Biol. 2005 Sep;78(3):675-85. Epub 2005 Jul 6.

PMID:
16000390
3.

Construction and characterisation of infectious recombinant HIV-1 clones containing CTL epitopes from structural proteins in Nef.

Guillon C, van Baalen CA, Boers PH, Verschuren EJ, Gruters RA, Osterhaus AD.

J Virol Methods. 2002 Jan;99(1-2):115-21.

PMID:
11684309
5.

Human immunodeficiency virus type 1 Nef protein modulates the lipid composition of virions and host cell membrane microdomains.

Brügger B, Krautkrämer E, Tibroni N, Munte CE, Rauch S, Leibrecht I, Glass B, Breuer S, Geyer M, Kräusslich HG, Kalbitzer HR, Wieland FT, Fackler OT.

Retrovirology. 2007 Oct 1;4:70.

6.

A novel small reporter gene and HIV-1 fitness assay.

Ali A, Yang OO.

J Virol Methods. 2006 Apr;133(1):41-7. Epub 2005 Nov 22.

PMID:
16307801
7.

Enhanced CD4 down-modulation by late stage HIV-1 nef alleles is associated with increased Env incorporation and viral replication.

Argañaraz ER, Schindler M, Kirchhoff F, Cortes MJ, Lama J.

J Biol Chem. 2003 Sep 5;278(36):33912-9. Epub 2003 Jun 19.

8.

Rodent cells support key functions of the human immunodeficiency virus type 1 pathogenicity factor Nef.

Keppler OT, Allespach I, Schüller L, Fenard D, Greene WC, Fackler OT.

J Virol. 2005 Feb;79(3):1655-65.

9.

Use of a macrophage-tropic GFP-tagged human immunodeficiency virus type 1 (HIV-1) to study viral reservoirs.

Brown AM.

Methods Mol Biol. 2009;515:165-75. doi: 10.1007/978-1-59745-559-6_11.

PMID:
19378134
10.

Functional characterization of HIV-1 Nef mutants in the context of viral infection.

Fackler OT, Moris A, Tibroni N, Giese SI, Glass B, Schwartz O, Kräusslich HG.

Virology. 2006 Aug 1;351(2):322-39. Epub 2006 May 8.

11.

Generation and characterization of HIV-1 clones chimeric for subtypes B and C nef.

Jere A, Piroozmand A, Tripathy S, Paranjape R, Sakurai A, Fujita M, Adachi A.

Int J Mol Med. 2004 Dec;14(6):1087-90.

PMID:
15547679
12.

Vpr is required for efficient Nef expression from unintegrated human immunodeficiency virus type 1 DNA.

Poon B, Chang MA, Chen IS.

J Virol. 2007 Oct;81(19):10515-23. Epub 2007 Jul 25.

13.

HIV-1 Nef mutations abrogating downregulation of CD4 affect other Nef functions and show reduced pathogenicity in transgenic mice.

Hanna Z, Priceputu E, Hu C, Vincent P, Jolicoeur P.

Virology. 2006 Mar 1;346(1):40-52. Epub 2005 Nov 28.

14.

[Influence of regulatory genes of type 1 human immunodeficiency virus on proliferation and differentiation of murine embryonic stem cells].

Manuilova ES, Arsen'eva EL, Khaĭdarova NV, Shugurova IM, Gornostaeva SN, Inozemtseva LS, Katrukha AI, Grivennikov IA, Tarantul VZ.

Ontogenez. 2003 May-Jun;34(3):204-10. Russian.

PMID:
12816051
15.

Selective elimination of HIV-1-infected cells by Env-directed, HIV-1-based virus-like particles.

Peretti S, Schiavoni I, Pugliese K, Federico M.

Virology. 2006 Feb 5;345(1):115-26. Epub 2005 Nov 4.

16.

Primary human immunodeficiency virus type 1 nef alleles show major differences in pathogenicity in transgenic mice.

Priceputu E, Hanna Z, Hu C, Simard MC, Vincent P, Wildum S, Schindler M, Kirchhoff F, Jolicoeur P.

J Virol. 2007 May;81(9):4677-93. Epub 2007 Feb 21.

17.

Modelling thymic HIV-1 Nef effects.

Stove V, Verhasselt B.

Curr HIV Res. 2006 Jan;4(1):57-64. Review.

PMID:
16454711
18.

Design, construction, and characterization of a multigenic modified vaccinia Ankara candidate vaccine against human immunodeficiency virus type 1 subtype C/B'.

Chen Z, Huang Y, Zhao X, Ba L, Zhang W, Ho DD.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):412-21. doi: 10.1097/QAI.0b013e3181651bb2.

PMID:
18209682
19.
20.

Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1.

Tanaka M, Ueno T, Nakahara T, Sasaki K, Ishimoto A, Sakai H.

Virology. 2003 Jul 5;311(2):316-25.

Supplemental Content

Support Center